Week of March 23, 2026

Geopolitical shock exposes structural vulnerabilities in health care supply chains

The ongoing conflict in the Middle East and the effective closure of the Strait of Hormuz has underscored how closely U.S. health care operations are tied to global geopolitics. These events have quickly translated into a wider supply chain and energy shock, exposing long‑standing vulnerabilities in pharmaceuticals, medical equipment and hospital cost structures.

For U.S. health care providers, the disruption is hitting at the convergence of rising costs and constrained supply. The industry’s dependence on globally distributed pharmaceutical manufacturing, particularly for generic drugs and active pharmaceutical ingredients, has become a central point of exposure. Nearly half of U.S. generic prescriptions are linked to production networks that rely on energy, petrochemical inputs and logistics corridors connected to the Gulf region.

Strains are also spreading through medical technology supply chains. Barclays said at least one publicly traded equipment maker has flagged potential exposure, pointing to PET/SPECT and ultrasound manufacturing in Israel alongside rising energy and semiconductor costs. While the company stopped short of quantifying the financial impact, they point to pandemic-era investments in supply chain flexibility as a buffer, an offset that offers limited relief for hospitals already grappling with tight capital budgets and energy-driven margin pressures.

Those stresses are amplified by structural features of the hospital supply base. About a quarter of hospital supplies spending is exposed to tariffs, and more than 25% is sourced outside the United States. That limits providers’ ability to pivot quickly when global shipping routes are disrupted and transportation costs spike.

The takeaway

In response, health systems are reassessing assumptions that once underpinned supply continuity. Diversifying sourcing has moved higher on the agenda. Providers are weighing higher‑cost defensive strategies. Inventory buffering, longer‑term contracting and alternative logistics routes are increasingly being used to preserve access to critical supplies.

While those measures can help cushion near‑term disruptions, they also reflect a broader shift: geopolitical risk is no longer a background consideration for health care supply chains. It is now a core operational variable, one that providers will need to manage alongside labor, reimbursement and capital constraints.

Learn more about what’s happening in health care in our industry outlook.